[Results of a new platelet function test in various clinical diseases and in preserved blood].
In healthy persons, patients with thrombocytopenia and patients with arterial disturbances of blood flow with and without administration of Falithrom the pressure recording was carried out after the combined aggregation and adhesion of thrombocytes. The reaction time particularly observed after administration of ADP revealed marked differences in the groups examined, likewise the maximal pressure amplitude in front of the pumped through filter. When Falithrom was administered the thrombocyte functions were clearly impaired. The reduction of the capacity of platelets to obstruct filter pores can impressively be proved even in those thrombocytes stored in ACD-AG-plasma.
D000244:Adenosine Diphosphate; D001778:Blood Coagulation Disorders / Q000097:blood / Q000188:drug therapy; D006801:Humans; D010644:Phenprocoumon / Q000627:therapeutic use; D010974:Platelet Aggregation; D013921:Thrombocytopenia / Q000097:blood*; D013922:Thrombocytosis / Q000097:blood*
D000244:Adenosine Diphosphate; D010644:Phenprocoumon
Ergebnisse eines neuen Thrombozytenfunktionstests bei verschiedenen klinischen Krankheitsbildern und gelagerten Blutkonserven.